Canada Life
ADMA icon

Canada Life’s ADMA Biologics ADMA Stock Holding History

Canada Life’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.76M Sell
195,783
-10,447
-5% -$165K ﹤0.01% 1189
2025
Q4 		$3.76M Sell
206,230
-45,692
-18% -$770K 0.01% 875
2025
Q3 		$3.7M Sell
251,922
-1,621
-0.6% -$27.8K 0.01% 958
2025
Q2 		$4.62M Sell
253,543
-5,919
-2% -$121K 0.01% 822
2025
Q1 		$5.14M Sell
259,462
-17,109
-6% -$296K 0.01% 776
2024
Q4 		$4.74M Sell
276,571
-3,937
-1% -$74.1K 0.01% 866
2024
Q3 		$5.61M Buy
280,508
+203,515
+264% +$3.16M 0.01% 807
2024
Q2 		$860K Buy
76,993
+22,944
+42% +$192K ﹤0.01% 1533
2024
Q1 		$357K Buy
54,049
+28,832
+114% +$158K ﹤0.01% 1749
2023
Q4 		$113K Hold
25,217
– – ﹤0.01% 1921
2023
Q3 		$90K Buy
25,217
+17,225
+216% +$66.3K ﹤0.01% 1983
2023
Q2 		$30K Hold
7,992
– – ﹤0.01% 2075
2023
Q1 		$26K Hold
7,992
– – ﹤0.01% 2163
2022
Q4 		$31K Buy
+7,992
New +$24.7K ﹤0.01% 2170
2015
Q3 		– Sell
-1,040
Closed -$9K – 2439
2015
Q2 		$9K Buy
+1,040
New +$8.99K ﹤0.01% 2537

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Canada Life's ADMA Position: Q1 2026 in Review

Canada Life reduced its ADMA Biologics (ADMA) stake by 5.1% in Q1 2026, selling an estimated $165K and leaving 195,783 shares worth $1.76M. The position accounts for ﹤0.01% of the portfolio, ranked #1189.

Canada Life first reported a position in ADMA in Q2 2015 and has held it in 15 quarters since. The position peaked at $5.61M in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Canada Life held 195,783 shares of ADMA Biologics worth $1.76M as of Q1 2026.
  • Canada Life sold 10,447 ADMA Biologics shares in Q1 2026, an estimated $165K.
  • ADMA Biologics made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1189 holding.
  • Canada Life first reported a position in ADMA Biologics in Q2 2015 and has held it in 15 quarters since.
  • Canada Life's ADMA Biologics position peaked at $5.61M in Q3 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.